Researchers at the University of Alabama at Birmingham will study individuals with genetic mutations associated with Parkinson’s disease as one of 32 clinical sites of the Parkinson’s Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J. Fox Foundation for Parkinson’s Research.
PPMI will enroll participants with a known mutation of the LRRK or SNCA [alpha-synuclein] gene. Previous research has shown these mutations are associated with Parkinson’s disease and account for a greater number of PD cases among certain ethnic populations and families, notably the LRRK2 mutation in those of Ashkenazi (Eastern European) Jewish, Basque and North African Berber descent. The insight investigators glean from these research volunteers will fortify current efforts to develop a disease-modifying therapy, something that currently eludes the field.
“Studying individuals with genetic mutations associated with Parkinson’s can accelerate our research toward a PD biomarker and more effective treatments,” said David Standaert, M.D., Ph.D., chair of the Department of Neurology and primary investigator at UAB. “Although known genetic mutations account for only five to 10 percent of all Parkinson’s cases, this population can provide invaluable information about the intricacies of the disease for all patients.”
PPMI is studying clinical and imaging data and biological samples of people with a genetic mutation to identify biomarkers and speed clinical trials. PPMI will enroll 250 people with the LRRK2 mutation and Parkinson’s, and 250 people with the mutation but without Parkinson’s. Since the SNCA mutation is more rare, the study is recruiting 50 people with Parkinson’s and the mutation, and 50 people with the SNCA mutation but without PD. These participants will be followed for five years.
Interested individuals can visit www.michaeljfox.org/ppmi/genetics, call 877-836-8108 or e-mail firstname.lastname@example.org. PPMI is particularly interested in testing individuals of Ashkenazi (Eastern European) Jewish descent or their relatives with Parkinson’s. The LRRK2 mutation also accounts for more PD cases in people of North African Arab Berber or Basque descent. Study sites will recruit people with the rarer SNCA mutation through familial connections.
Biomarkers — such as cholesterol level for heart disease — are substances, processes or characteristics of the body that communicate disease risk, onset and/or progression. They aid in diagnosis and disease management and help researchers stratify for clinical trials and test new drugs more quickly by measuring biological changes rather than waiting for clinical improvement. There are no validated biomarkers for Parkinson’s disease, a reality researchers are hoping to change with PPMI.
Launched in 2010, PPMI is a longitudinal clinical study that collects standardized clinical, imaging and biologic data. Now taking place at 32 clinical sites around the world, the study completed initial enrollment of 423 recently diagnosed Parkinson’s patients and 196 controls in April 2013. That month, PPMI began recruiting individuals with the known Parkinson’s risk factors of smell loss and REM sleep behavior disorder.
“In the fourth year of PPMI, it is evident that a large-scale biomarker study is not only possible in Parkinson’s disease, but is already yielding scientific insights that could help transform the field of Parkinson’s research,” said Todd Sherer, Ph.D., CEO of The Michael J. Fox Foundation. “The exceptional investigators at sites around the world, such as at UAB, have created the infrastructure that allows us to make such strides, by working together.”
American Cancer Society honors WalkerWalker of the UAB School of Nursing was one of six health care professionals honored by the ACS with a prestigious national award.posted 3 days ago 744 viewsUAB developing new peptide to combat a disorder that causes heart attacks at early ageSome people inherit a condition that elevates their cholesterol to an excessive degree, and no amount of diet or exercise can bring the numbers down. UAB researchers are developing and testing a new peptide that may lead to better treatment options.posted 2 days ago 1426 viewsSpecialized cancer centers play a role in survival of adolescents and young adults with acute leukemiaA UAB study shows specialized treatment sites contribute to better survival rates for those with acute leukemia.posted 7 days ago 1929 viewsNew Women’s Heart Health Clinic provides specialized careAccording to the National Heart, Lung and Blood Institute, 23 percent of women will die within one year after having a heart attack , and nearly 46 percent of women become disabled with heart failure.posted 7 days ago 4081 viewsPhysical Medicine and Rehabilitation receives funding for two longstanding centersThe UAB Department of Physical Medicine and Rehabilitation is one of the Southeast’s foremost providers of comprehensive rehabilitation care.posted 8 days ago 645 viewsDothan man sees improvement in quality of life after LVAD surgeryJames Ward could not walk from his office to his car without having trouble breathing until a life-changing heart pump gave him hope.posted 9 days ago 7242 viewsNew cavity treatment offers no drilling, no fillingUAB School of Dentistry is offering patients with cavities between teeth a new, less painful option for treatment in a new clinical trial.posted 10 days ago 2312 viewsPeruvian native to lead top global tropical medicine training center at UABUAB names new leadership for Gorgas Center for Geographic Medicine.posted 10 days ago 1088 viewsUAB first in Alabama to implement new FDA-approved PFO occluderMassoud Leesar, M.D., performed the first procedure Jan. 25, 2017, and that is good news for people who suffer strokes as a result of patent foramen ovale, or PFO.posted 14 days ago 903 viewsThis Heart Month, know the foods that protect against cardiovascular diseaseAccording to the American Heart Association, heart disease is the leading global cause of death. These foods can promote cardiovascular health.posted 16 days ago 2760 viewsStandard therapy used in pediatric cardiac ICU challenged by study in NEJMUAB researchers looked at body cooling versus normal temperature control in pediatric patients who suffered cardiac arrest in the hospital to find that neither is more beneficial.posted 20 days ago 1104 viewsResearchers develop best-yet cell culture system for age-related macular degenerationChristine Curcio, Ph.D., led an international team of researchers that developed a culture system for age-related macular degeneration, the third most prevalent cause of vision loss worldwide.posted 22 days ago 2496 viewsUAB celebrates Heart Month 2017 with communityThroughout the month of February, the University of Alabama at Birmingham, UAB Medicine, and Heart and Vascular Services will raise awareness about heart disease and ways to help prevent it as part of American Heart Month with many events, including three communitywide initiatives.posted 23 days ago 1434 viewsUAB launches comprehensive interventional pulmonary programUAB has created the only comprehensive interventional pulmonary medicine program in Alabama to better diagnose and treat lung and chest diseases.posted 24 days ago 1386 viewsUAB School of Nursing breaks down more barriers to health care with new $1.4 million grantExpanded partnership with Aletheia House will provide increased access to medically underserved populations in Bessemer.posted 24 days ago 2042 viewsRecord baby boom at UAB HospitalUAB’s Women and Infants Center delivered 4,400 babies in 2016.posted 27 days ago 994 viewsUAB’s novel lay navigation program demonstrates significant cuts in cancer care costs, serves as national modelUAB’s innovative Patient Care Connect Program utilizes lay navigation and provides a cost-effective new model for cancer care delivery.posted 28 days ago 2600 viewsUAB and VICIS announce partnership to deliver safer football helmetsUAB and VICIS have each made major strides in developing next generation football helmets in response to the growing concussion crisis, and they have partnered to combine expertise and intellectual property to bring more effective helmets to the market.posted a while back 6289 viewsUAB involved in critical NIH study that identifies genomic features of cervical cancerA significant new study by The Cancer Genome Atlas Research Network, including a UAB physician-scientist, uncovers genetic mutations of cervical cancer that hold a key to targeting and treating the disease.posted a while back 2858 viewsUAB receives $16 million grant to reduce cancer disparitiesThe UAB Comprehensive Cancer Center has received a $16 million NCI renewal grant to advance cancer disparities research and reduce mortality rates among underserved populations.posted a while back 4679 views